Syndromes of resistance to thyroid hormone: Clinical considerations;Les syndromes de resistance aux hormones thyroidiennes: Aspects cliniques

Revue de Medecine Interne

Volumn 20, Issue 12, 1999, Pages 1114-1122

  Vlaeminck Guillem, V ^a   Wemeau J L ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

High levels of circulating thyroid hormones; Inappropriate secretion of TSH; Resistance to thyroid hormone

Indexed keywords

DEXTROTHYROXINE; LIOTHYRONINE; LIOTHYRONINE RECEPTOR; THYROID HORMONE; THYROTROPIN; TIRATRICOL; THYROID HORMONE RECEPTOR;

AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; EUTHYROIDISM; GENETIC DISORDER; GENETIC VARIABILITY; HORMONE RESISTANCE; HUMAN; HYPOPHYSIS ADENOMA; PHENOTYPE; RADIOTHERAPY; REVIEW; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL; THYROID SURGERY; THYROTOXICOSIS; BLOOD; GENETICS; HOSPITALIZATION; PATHOPHYSIOLOGY; PROGNOSIS; SECRETION; THYROID HORMONE RESISTANCE;

HUMANS; PHENOTYPE; PROGNOSIS; RECEPTORS, THYROID HORMONE; SEVERITY OF ILLNESS INDEX; THYROID HORMONE RESISTANCE SYNDROME; THYROTROPIN;

EID: 0033431652     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)87525-6     Document Type: Review

References (59)

1. Refetoff S, DeWind LT, DeGroot LJ. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J Clin Endocrinol Metab 1967; 27: 279-94.
2. Albright F, Burnett CH, Smith PH, Parson W. Pseudo-hypoparathyroidism. An example of "Seabright-Bantam syndrome". Endocrinology 1942; 30: 922-32.
3. Refetoff S. Resistance to thyroid hormone. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid. 7 Ed. Philadelphia: Lippincott-Raven; 1996. p. 1032-48.
4. Gershengorn MC, Weintraub BD. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH". J Clin Invest 1975; 56: 633-42.
5. Kaplan MM, Swartz SL, Larsen PR. Partial peripheral resistance to thyroid hormone. Am J Med 1981; 70: 1115-21.
6. Usala SJ. Molecular diagnosis and characterization of thyroid hormone resistance syndromes. Thyroid 1991; 1: 361-7.
7. Refetoff S. Resistance to thyroid hormone: An historical overview. Thyroid 1994; 4: 345-9.
8. Beck-Peccoz P, Chatterjee VK. The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 1994; 4: 225-32.
9. Pagliara AS, Caplan RH, Gundersen CB, Wickus GG, Elston AC. Peripheral resistance to thyroid hormone in a family: Heterogeneity of clinical presentation. J Pediatr 1983; 103: 228-32.
10. Collingwood TN, Rajanayagam O, Adams M, Wagner R, Cavaillès V, Kalkhoven E, et al. A natural transactivation mutation in the thyroid hormone beta receptor: Impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci USA 1997; 94: 248-53.
11. Chatterjee VKK. Resistance to thyroid hormone. Horm Res 1992; 48 Suppl. 4: 43-6.
12. Franklyn JA. Thyroid hormone resistance syndromes. Are generalized and selective pituitary resistance part of the same disorder? Clin Endocrinol (Oxf) 1993; 38: 235-6.
13. Tsukaguchi H, YOshimasa Y, Fujimoto K, Ischii H, Yamamoto T, Yoshimasa T, et al. Three novel mutations of thyroid receptor beta gene in unrelated patients with resistance to thyroid hormones: Two new mutations of the same codon (H435L and H435Q) produce separate subtypes of resistance. J Clin EndoCrinol Metab 1995; 80: 3613-6.
14. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, et al. Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci USA 1989; 86: 8977-81.
15. Sap J, Muñoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635-40.
16. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986; 324: 641-6.
17. De Nayer P. The thyroid hormone receptors: Molecular basis of thyroid hormone resistance. Horm Res 1992; 38: 57-61.
18. Macchia E, Nakai A, Janiga A, Sakurai A, Fisfalen ME, Gardner P, et al. Characterization of site-specific polyclonal antibodies to c-erbA peptides recognizing human thyroid hormone receptors alpha1, alpha2, and beta and native 3,5,3'-triiodothyronine receptor, and study of tissue distribution of the antigene. Endocrinology 1990; 126: 3232-9.
19. Beck-Peccoz P, Asteria C, Mannavola D. Resistance to thyroid hormone. In: Braverman LE, ed. Diseases of the Thyroid. Totawa, New Jersey: Humana Press; 1997. p. 199-239.
20. Torresani J. Mécanismes d'action des hormones thyroïdiennes. Récepteurs nucléaires. In: Leclère J, orgiazzi J, rousset B, schlienger JL, wémeau JL, eds. La Thyroïde. Paris: Expansion Scientifique Française; 1992. p. 126-35.
21. Koenig RJ. Thyroid hormone receptor coactivators and corepressors. Thyroid 1998; 8: 703-13.
22. Chin WW, Yen PM. Molecular mechanisms of nuclear thyroid hormone action. In: Braverman LE, ed. Diseases of the Thyroid. Totawa, New Jersey: Humana Press; 1997. p. 1-15.
23. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, et al. Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erbA beta gene. Mol Endocrinol 1988; 2: 1217-20.
24. Vlaeminck-Guillem V, Wémeau JL. Syndromes de résistance aux hormones thyroïdiennes: Bases moléculaires et pathogéniques. Méd Sci 1997; 13: 1419-27.
25. Hayashi Y, Weiss RE, Sarne DH, Yen PM, Sunthornthepvarakapul T, Marcocci C, et al. Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-β receptor. J Clin Endocrinol Metab 1995; 80: 3246-56.
26. Refetoff S, Weiss RE, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14: 348-99.
27. Takeda K, Sakurai A, DeGroot LJ, Refetoff S. Recessive inheritance of thyroid hormone resistance caused by complete deletion of the protein-coding region of the thyroid hormone receptor- Beta gene. J Clin Endocrinol Metab 1992; 74: 49-55.
28. Refetoff S. The syndrome of generalized resistance to thyroid hormone (GRTH). Endocr Res 1989; 15: 717-43.
29. Wémeau JL. Syndromes de résistance aux hormones thyroïdiennes. In: Leclère J, Orgiazzi J, Rousset B, Schlienger JL, Wémeau JL, eds. La Thyroïde. Paris: Expansion Scientifique Française; 1992. p. 413-9.
30. MeChain C, Leger A, Feldman S, Kuttenn F, Mauvais-Jarvis P. Syndromes de résistance aux hormones thyroïdiennes. Presse Méd 1993; 22: 1870-5.
31. Jaffiol C, De Boisvilliers F, BaLdet L, Torresani J. Thyroid hormone generalized resistance. Horm Res 1992; 38: 62-5.
32. Brucker-Davis F, Skarulis MC, Grace MB, Benichou J, Hauser P, Wiggs E, et al. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. Ann Intern Med 1995; 123: 572-83.
33. Weiss RE, Stein MA, Duck SC, Chyna B, Phillips W, O'Brien T, et al. Low intelligence but not attention deficit hyperactivity disorder is associated with a resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor beta gene. J Clin Endocrinol 1994; 78: 1525-8.
34. Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 1993; 328: 997-1001.
35. Weiss RE, Stein MA, Trommer B, Refetoff S. Attention-deficit hyperactivity disorder and thyroid function. J Pediatr 1993; 123: 539-45.
36. Brucker-Davis F, Skarulis MC, Pikus A, Ishizawar D, Mastroianni MA, Koby M, et al. Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 1996; 81: 2768-72.
37. Ono S, Schwartz ID, Mueller OT, Root AW, Usala SJ, Bercu BB. Homozygosity for a dominant negative thyroid hormone receptor gene responsible for generalized resistance to thyroid hormone. J Clin Endocrinol Metab 1991; 73: 990-4.
38. Frank-Raue K, Höppner W, Boll HU, Raue F. Severe form of thyroid hormone resistance in homozygous mutation in the thyroid hormone receptor β gene. Exp Clin Endocrinol Diabetes 1998; 106 suppl 1: S16.
39. Beck-Peccoz P, Forloni F, Cortelazzi D, Persani L, Papandreou MJ, Asteria C, et al. Pituitary resistance to thyroid hormones. Horm Res 1992; 38: 66-72.
40. McDermott MT, Ridgway EC. Thyroid hormone resistance syndromes. Am J Med 1993; 94: 424-32.
41. Smallridge RC, Parker RA, Wiggs EA, Rajagopal KR, Fein HG. Thyroid hormone resistance in a large kindred: Physiologic, biochemical, pharmacologic, and neuropsychologic studies. Am J Med 1989; 86: 289-96.
42. Weiss RE, Balzano S, Scherberg NH, Refetoff S. Neonatal detection of generalized resistance to thyroid hormone. JAMA 1990; 264: 2245-50.
43. Wong GWK, Shek CC, Lam STS, Tsui MKM, Leung SSF. Detection of resistance to thyroid hormone by cord blood screening. Acta Paediatr 1995; 84: 335-6.
44. Franklyn JA. Syndromes of thyroid hormone resistance. Clin Endocrinol 1991; 34: 237-45.
45. Schlienger JL. Pathologie générale et thyroïde. In: Leclère J, Orgiazzi J, Rousset B, Schlienger JL, Wémeau JL, eds. La ThyRoïde. Paris: Expansion Scientifique Française; 1992. p. 527-41.
46. Weintraub BD, Menezes-Ferreira MM, Petrick PA. Inappropriate secretion of TSH. Endocr Res 1989; 15: 601-17.
47. Akiyoshi F, Okamura K, Fujikawa M, Sato K, Yoshinari M, Mizokami T, et al. Difficulty in differentiating thyrotropin secreting pituitary microadenoma from pituitary-selective thyroid hormone resistance accompanied by pituitary incidentaloma. Thyroid 1996; 6: 619-25.
48. Gurnell M, Rajanayagam O, Barbar I, Jones MK, Chatterjee VK. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid 1998; 8: 679-82.
49. Dulgeroff AJ, Geffner ME, Koyal SN, Wong M, Hershman JM. Bromocriptine and triac therapy for hyperthyroidism due to pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 1992; 75: 1071-5.
50. Hamon P, Bovier-Lapierre M, Robert M, Peynaud D, Pugeat M, Orgiazzi J. Hyperthyroidism due to selective pituitary resistance to thyroid hormones in a 15-month-old boy: Efficacy of D-thyroxine therapy. J Clin Endocrinol Metab 1988; 67: 1089-93.
51. Krawczynska H, WojciK-Musialek K, Illig R. Ten years of successful treatment with dextrothyroxine in a girl with TSH-induced hyperthyroidism. Horm Res 1991; 35: 213-6.
52. Takeda T, Suzuki S, Liu RT, DeGroot LJ. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J Clin Endocrinol Metab 1995; 80: 2033-40.
53. Pohlenz J, Knöbl D. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy. Acta Paediatr 1996; 85: 387-90.
54. Kopp P, Kitajima K, Jameson JL. Syndrome of resistance to thyroid hormone: Insights into thyroid hormone action. Proc Soc Exp Biol Med 1996; 211: 49-61.
55. Behr M, Ramsden DB, Loos U. Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab 1997; 82: 1081-7.
56. Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D, et al. Prenatal diagnosis of thyroid hormone resistance. J Clin Endocrinol Metab 1999; 84: 405-10.
57. Weiss RE, Refetoff S. Treatment of resistance to thyroid hormone - Primum non nocere. J Clin Endocrinol Metab 1999; 84: 401-4.
58. A registry for resistance to thyroid hormone. J Clin Endocrinol Metab 1994; 79: 1560.
59. Weiss RE, Marcocci C, Bruno-Bossio G, Refetoff S. Multiple genetic factors in the heterogeneity of thyroid hormone resistance. J Clin Endocrinol Metab 1993; 76: 257-9.